Puma BioTech
PBYI7.9900.13% ( +0.010 )
Puma BioTech (PBYI)
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States...
- Open
- 8.040
- High
- 8.180
- Low
- 7.990
- Prev. Close
- 7.980
- Volume
- 143.87K
- Turnover
- 1.16M
- Avg Price
- 8.044
- Bid/Ask Ratio
- --
- Amplitude
- 2.38%
- 52wk High
- 8.750
- Volume Ratio
- 0.40
- Turnover Ratio
- 0.37%
Puma BioTech Analyst Rating
View MoreForecast & Rating
May 8, 2026Price forecast
$5.00-37.42%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 23 at 03:27 PM
Puma Biotechnology schedules conference call on Q2 2026 results
- Market Beat · Jul 9 at 05:53 AM
Douglas Hunt Sells 8,460 Shares of Puma Biotechnology (NASDAQ:PBYI) Stock
- PUBT · Jul 8 at 07:19 PM
Puma Biotech CFO Maximo F. Nougues disposes of 9,386 shares for $77,560.24
- benzinga_article · Jul 7 at 04:05 PM
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Tip Ranks · May 8 at 07:20 PM
Puma Biotechnology Raises Outlook Despite Q1 Reset
- Earnings Watch · May 7 at 04:14 PM
Puma BioTech | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 44.81 M
